DOCSLIB.ORG

Ketosis in Hepatic Glycogenosis J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ketosis in Hepatic Glycogenosis J Arch Dis Child: first published as 10.1136/adc.47.251.41 on 1 February 1972. Downloaded from Archives of Disease in Childhood, 1972, 47, 41. Ketosis in Hepatic Glycogenosis J. FERNANDES* and N. A. PIKAAR From the Department of Paediatrics, The University, Utrecht, and Central Institute for Nutrition and Food Research, Zeist, The Netherlands Fernandes, J., and Pikaar, N. A. (1972). Archives of Disease in Childhood, 47, 41. Ketosis in hepatic glycogenosis. The occurrence of ketosis in 41 patients with liver glycogenosis and a control group of 22 children was investigated. Fasting ketosis was present in children with a deficiency of the debranching enzyme system and in young children with a deficiency of the phosphorylase system, but never in patients with a glucose-6-phosphatase deficiency. Oral tolerance tests on a patient deficient in debranching enzyme showed that the blood levels of glucose and ketone bodies changed in the opposite direction. It is argued that, for biochemical reasons, the occurrence of ketosis in patients with a glucose- 6-phosphatase deficiency is improbable. Ketosis has generally been considered to be a (Howell et al., 1962; Hug and Schubert, 1967; characteristic feature of glycogen storage disease Kelsch and Oliver, 1969; Rennert and Mukhopad- in childhood (van Creveld, 1928, 1932; Howell, hyay, 1968). Because of the conflicting evidence Ashton, and Wyngaarden, 1962; Hug and Schubert, we decided to gather more data on ketosis in patients copyright. 1967; Kelsch and Oliver, 1969; Lowe et al., 1962; with the three most common types of glycogenosis, Rennert and Mukhopadhyay, 1968; Sidbury, e.g. glucose-6-phosphatase deficiency, deficiency Gitzelmann, and Fisher, 1961; Sokal et al., 1961). of the debranching enzyme system, and deficiency While studying some aspects of the carbohydrate of the phosphorylase system. and fat metabolism of children with glycogenosis of the liver (Fernandes and van de Kamer, 1965; Patients and Methods Fernandes and Pikaar, 1969), we were puzzled by The investigation comprised 41 patients and 22 normal the fact that, though we frequently encountered children. The relevant clinical and biochemical data http://adc.bmj.com/ fasting ketosis in our debranching enzyme- and of the patients are presented in Tables I-III. The phosphorylase-deficient patients, we never saw patients with a glucose-6-phosphatase deficiency were it in our patients with glucose-6-phosphatase diagnosed by enzymic assay of a liver biopsy (Table I). deficiency. The patients with a deficiency ofthe debranching enzyme The normal fasting levels of ketone bodies in the system were diagnosed by enzymic assay of the leuco- blood of the latter seemed the more unexpected as cytes: in three of them an enzymic assay of a liver they have the strongest tendency towards hypo- glycaemia of all types of glycogenosis patients, and TABLE I on September 26, 2021 by guest. Protected it is known that hypoglycaemia causes a rise of the Enzyme Assays in 5 Children with Glucose-6- free fatty acid concentration in the plasma. Thus, phosphatase Deficiency under hypoglycaemic conditions one might expect an enhanced rate of fatty acid oxidation and ketone Case No. Glucose-6-phosphatase in Liver body synthesis in the liver to compensate for the 1 0.07* deficient glucose supply. Therefore, in glucose-6- 2 0 00* phosphatase deficiency even more than in other 3 0.08* 4 0° OOt types of glycogenosis, ketosis would be expected to 5 00°°t occur frequently. Indeed, many authors implicitly assume, or even explicitly state, this to be the case *,moles Pi/min per g tissue (Hers, 1964), normal range 2-10. Enzyme assays by Professor H. G. Hers (Louvain). Received 29 July 1971. t gmoles Pi/min per mg protein measured on the total homogenate *Present address: Sophia Children's Hospital and Neonatal Unit, (Harper, 1962), normal range 5 9-93 (N = 7). Enzyme assays by Rotterdam Medical School, Rotterdam, The Netherlands. Dr. J. F. Koster (Rotterdam). 41 Arch Dis Child: first published as 10.1136/adc.47.251.41 on 1 February 1972. Downloaded from 42 Fernandes and Pikaar TABLE II TABLE III Enzyme Assays of 7 Children with Deficiency of Enzyme Assays of 29 Children with Deficiency of Debranching Enzyme System Phosphorylase System Debranching Enzyme Phosphorylase b Phosphorylase in Phosphorylase Case Case Kinase in Leucocytes (2) b Kinase No. Leucocytes Liver No.No. Leucocytes (1) -AMP + AMP in Liver (1) (1) (2) (1) (2) 1 0-57 5 15 - 1 0-00 - - - 2 0-11 5 24 0-16 2 0 00 0 00 0 00 0 00 3 0-11 3 13 - 3 0 06 0-00 0-13 0-00 4 0 09 2 21 - 4 0 00 - - - 5 0-08 8 21 - 5 0 00 - - - 6 0-10 - - - 6 0-00 - - - 7 0-08 4 15 - 7 0-00 0-25 0-20 0-25 8 0-41;0-55 6 13 - 9 0 04 2 13 - Normal 0-33-1-59 0-31-0-51 0-51-2-30 0-13-0-61 10 0 07 4 11 - range N=6 N=2 N=5 N=4 11 0-08 3 14 - 12 0-08 3 16 - 13 0 06 1 23 - (1) nmoles glucose produced from phosphorylase limit dextrin/ 14 0-00 3 20 - min per mg protein (Huijing, 1964). 15 0 04 4 17 0-06 (2) nmoles glucose incorporated/mm per mg protein (Hers, 1964). 16 0 09 5 16 - The enzyme assays were performed by Dr. J. H. van de Kamer 17 0-07 6 15 - (Utrecht), Dr. J. F. Koster (Rotterdam), or Professor H. G. Hers 18 0-12 7 15 - (Louvain). 19 0-11 4 14 - 20 0-16 2 17 - 21 0 09 4 17 - biopsy was performed as well (Table II). The patients 22 0-02 5 21 - with a deficiency of the phosphorylase system were 23 0 09 3 16 - diagnosed by enzymic assay of the leucocytes (Table 24 0-02 0 3 - III). These patients, Cases 1 and 8 to 25 0-07 3 16 - excepted, belong 26 0-08 4 23 - the phosphorylase kinase-deficient type (Huijing, 1967); 27 0 12 3 22 0-09 copyright. most belong to two large pedigrees (Huijing and Fer- 28 0-10 4 18 - nandes, 1969). 29 0-05 3 17 _ The finding of a deficiency of phosphorylase kinase Normal 0-56 + 0-19 19 ± 6 24 + 6 0 27-098 in the leucocytes was confirmed by enzymic assay of a (Mean + SD) (Mean + SD) (Range) liver biopsy in Cases 2, 15, and 27. N = 58 N = 39 N = 39 N- 5 The ketone bodies, acetone, 3-ketobutyrate, and 3- hydroxybutyrate were estimated separately in capillary (1) Units phosphorylase b activated/min per mg protein (Huijing, blood. The method of Peden (1964) was used in a 1967). (2) nmoles glucose-l-phosphate produced from soluble starch/min scaled-down version. The results were the same as with per mg protein (Huijing, 1967). The enzyme assays in the leuco- http://adc.bmj.com/ the original method. cytes were performed by Dr. F. Huijing (Miami), those in the liver Glucose was estimated with glucose oxidase (reagent by Dr. J. F. Koster (Rotterdam). set TC-M of Boehringer and Soehne, Mannheim, West Dr. F. Huijing kindly gave advice on the adaptation of his method Germany), and nonesterified fatty acids (NEFA) were of phosphorylase kinase assay in leucocytes to liver biopsies. estimated with a micromodification of Dole's method in with a (Fernandes and van de Kamer, 1965; Trout, Estes, and patients glucose-6-phosphatase deficiency. Friedberg, 1960). The fasting ketone body level in the phosphorylase- As regards the procedure of the oral tolerance tests, deficient patients is age-dependent (Fig. 2): the 2 g glucose or casein per kg body weight was administered tendency towards ketosis declines with age to on September 26, 2021 by guest. Protected as a 10% solution. disappear around the age of 7. Results Additional experiments. After oral glucose General survey. Fig. 1 represents the fasting administration to a patient with a debranching blood levels of total ketone bodies in patients with enzyme deficiency, the fasting ketosis disappeared different types of liver glycogenosis and controls. completely (Fig. 3A). The administration of The preceding fasting period was 8 to 14 hours galactose or fructose to the same patient had an except for one infant with a glucose-6-phosphatase equally favourable effect (data not shown). Oral deficiency whose tendency towards hypoglycaemia casein administration to this patient was followed did not permit a fast longer than 4 to 6 hours. by only slight decrease in the ketosis (Fig. 3B). A striking ketosis was present in most children with In the same child with a debranching enzyme a debranching enzyme deficiency and several deficiency, ketone body concentrations were esti- children with a phosphorylase deficiency, but not mated during prolonged fasting. Before the test, Arch Dis Child: first published as 10.1136/adc.47.251.41 on 1 February 1972. Downloaded from Ketosis in Hepatic Glycogenosis 43 r I I I o 50- 4, 0 Z 70- 40- to II 0 0 0 E 0 0 E 30- un 0 U, 0 05 0 E a * 0 m 20- w 00 w z lU 0 * 0 30 1-- -J 10 - LU x . I- o * * X 0 0 I.- X0 00 X .o 10- 111111 111511111111111 8 II I I I I I I II I I I I I I I I I I I 5 10 15 20 a-. .- -- AGE IN YEARS MEAN 4.1 45.5 9.5 3.7 RANGE 0,4 - 10.3 9.9 - 2.0 - 0.1 - 77.1 44A 10O FIG.
Load more

Recommended publications
  • The Limited Role of Glucagon for Ketogenesis During Fasting Or in Response to SGLT2 Inhibition
    882 Diabetes Volume 69, May 2020 The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition Megan E. Capozzi,1 Reilly W. Coch,1,2 Jepchumba Koech,1 Inna I. Astapova,1,2 Jacob B. Wait,1 Sara E. Encisco,1 Jonathan D. Douros,1 Kimberly El,1 Brian Finan,3 Kyle W. Sloop,4 Mark A. Herman,1,2,5 David A. D’Alessio,1,2 and Jonathan E. Campbell1,2,5 Diabetes 2020;69:882–892 | https://doi.org/10.2337/db19-1216 Glucagon is classically described as a counterregula- the oxidation of fatty acids, a shift in fuel utilization that tory hormone that plays an essential role in the pro- coordinates energy needs and glucose production (2). The tection against hypoglycemia. In addition to its role in actions of glucagon to increase lipid oxidation, including the regulation of glucose metabolism, glucagon has the production of ketone bodies that is a downstream end been described to promote ketosis in the fasted state. point of this process, have been defined by numerous – Sodium glucose cotransporter 2 inhibitors (SGLT2i) are experiments with cultured hepatocytes (3–5). Moreover, a new class of glucose-lowering drugs that act primarily the classic studies of Gerich et al. (6), using somatostatin to in the kidney, but some reports have described direct reduce circulating glucagon and mitigate diabetic ketoaci- effects of SGLT2i on a-cells to stimulate glucagon se- dosis (DKA), add to the now ingrained belief that glucagon cretion. Interestingly, SGLT2 inhibition also results in increased endogenous glucose production and ketone has both glucogenic and ketogenic activities.
    [Show full text]
  • Defective Galactose Oxidation in a Patient with Glycogen Storage Disease and Fanconi Syndrome
    Pediatr. Res. 17: 157-161 (1983) Defective Galactose Oxidation in a Patient with Glycogen Storage Disease and Fanconi Syndrome M. BRIVET,"" N. MOATTI, A. CORRIAT, A. LEMONNIER, AND M. ODIEVRE Laboratoire Central de Biochimie du Centre Hospitalier de Bichre, 94270 Kremlin-Bicetre, France [M. B., A. C.]; Faculte des Sciences Pharmaceutiques et Biologiques de I'Universite Paris-Sud, 92290 Chatenay-Malabry, France [N. M., A. L.]; and Faculte de Midecine de I'Universiti Paris-Sud et Unite de Recherches d'Hepatologie Infantile, INSERM U 56, 94270 Kremlin-Bicetre. France [M. 0.1 Summary The patient's diet was supplemented with 25-OH-cholecalci- ferol, phosphorus, calcium, and bicarbonate. With this treatment, Carbohydrate metabolism was studied in a child with atypical the serum phosphate concentration increased, but remained be- glycogen storage disease and Fanconi syndrome. Massive gluco- tween 0.8 and 1.0 mmole/liter, whereas the plasma carbon dioxide suria, partial resistance to glucagon and abnormal responses to level returned to normal (18-22 mmole/liter). Rickets was only carbohydrate loads, mainly in the form of major impairment of partially controlled. galactose utilization were found, as reported in previous cases. Increased blood lactate to pyruvate ratios, observed in a few cases of idiopathic Fanconi syndrome, were not present. [l-14ClGalac- METHODS tose oxidation was normal in erythrocytes, but reduced in fresh All studies of the patient and of the subjects who served as minced liver tissue, despite normal activities of hepatic galactoki- controls were undertaken after obtaining parental or personal nase, uridyltransferase, and UDP-glucose 4epirnerase in hornog- consent. enates of frozen liver.
    [Show full text]
  • Improvement of the Nutritional Management of Glycogen Storage Disease Type I
    1 Improvement of the nutritional management of glycogen storage disease type I Kaustuv Bhattacharya Presented for the degree of MD (res) at University College London 2 “The roots below the earth claim no rewards for making the branches fruitful” Sir Rabrindranath Tagore Stray Birds (1917) Acknowledgements Whilst this thesis is my own work, it is the product of several helpful discussions with many people around the world. It was conducted under the supervision of Philip Lee who, since completion of the data collection, faced bigger personal challenges than he could have imagined. I hope that this work is a fitting conclusion to one strategic direction, of some of his research, which I hope he can be proud of. I am very grateful for his help. Peter Clayton has been a source of inspiration throughout my “metabolic” career and his guidance throughout this process has been very gratefully received. I appreciate the tolerance of my other colleagues at Queen Square and Great Ormond Street Hospital that have accommodated in different ways. The dietetic experience of Maggie Lilburn has been invaluable to this work. Simon Eaton has helped tremendously with performing the assays in chapter 5. I would also like to thank, David Morley, Amy Cole, Martin Christian, and Bridget Wilcken for their constructive thoughts. None of this work would have been possible without the Murphy family’s generous support. I thank the Dromintee Trust for keeping me in worthwhile employment. I would like to thank the patients who volunteered and gave me so much of their time. The Association for Glycogen Storage Disease (UK), Glycologic Ltd and Vitaflo Ltd have also sponsored these trials and hopefully facilitated a better experience for patients.
    [Show full text]
  • General Nutrition Guidelines for Glycogen Storage Disease Type III
    General Nutrition Guidelines For Glycogen Storage Disease Type III Glycogen Storage Disease Type III (GSDIII) is a genetic metabolic disorder which causes the inability to break down glycogen to glucose. Glycogen is a stored form of sugar in the body. Glucose (sugar) is the main source of fuel for the body and brain. GSD IIIa causes the inability of the liver and muscles to breakdown glycogen to glucose. GSD IIIb causes the inability of the liver to breakdown glycogen to glucose. As a result of the inability to breakdown glycogen, patients with GSDIII are at risk for low blood sugars (hypoglycemia) during periods of fasting. Patients with GSDIIIa also do not have the ability to access glycogen in their muscles as well. The lack of glycogen access in the muscles causes muscle damage as the muscle do not have a fuel to aid them in working. The following is a recommended general nutrition guideline for those with GSDIII to help maximize blood sugar control, nutrition, energy, and hopefully minimize muscle damage for those with GSDIIIa. Protein What is protein? Protein is a macronutrient (like carbohydrate and fat) and is required for proper growth and development. In GSDIII, the most important role that protein serves is a way for the body to make glucose since those with GSDIII do not have access to stored sugars (glycogen). Protein also serves as the building blocks for our cells, is also necessary to make antibodies which help our bodies fight off illnesses, make up hormones, enzymes, and even our DNA. With GSD type III, it is very important to make sure you are getting all the protein that your body needs.
    [Show full text]
  • Ketosis Diagnosis and Monitoring in High-Producing Dairy Cows
    Review Invited Review: Ketosis Diagnosis and Monitoring in High-Producing Dairy Cows Mariana Alves Caipira Lei 1 and João Simões 2,* 1 Department of Zootechnics, School of Agricultural and Veterinary Sciences, University of Trás-os-Montes e Alto Douro (UTAD), 5000-801 Vila Real, Portugal; [email protected] 2 Department of Veterinary Sciences, School of Agricultural and Veterinary Sciences, University of Trás-os-Montes e Alto Douro (UTAD), 5000-801 Vila Real, Portugal * Correspondence: [email protected]; Tel.: +351-259-350-666 Abstract: This work reviews the current impact and manifestation of ketosis (hyperketonemia) in dairy cattle, emphasizing the practical use of laboratory methods, field tests, and milk data to monitoring this disease. Ketosis is a major issue in high-producing cows, easily reaching a prevalence of 20% during early postpartum when the negative energy balance is well established. Its economic losses, mainly related to decreasing milk yield, fertility, and treatment costs, have been estimated up to €250 per case of ketosis/year, which can double if associated diseases are considered. A deep relationship between subclinical or clinical ketosis and negative energy balance and related production diseases can be observed mainly in the first two months postpartum. Fourier transform infrared spectrometry methods gradually take place in laboratory routine to evaluates body ketones (e.g., beta-hydroxybutyrate) and probably will accurately substitute cowside blood and milk tests at a farm in avenir. Fat to protein ratio and urea in milk are largely evaluated each month in dairy farms indicating animals at risk of hyperketonemia. At preventive levels, other than periodical evaluation of body condition score and controlling modifiable or identifying non-modifiable risk Citation: Lei, M.A.C.; Simões, J.
    [Show full text]
  • Therapeutics of Corticosteroids in the Bovine Animal and Problems Surrounding Their Use W
    Therapeutics of Corticosteroids in the Bovine Animal and Problems Surrounding Their Use W. D. Black, D. V.M.· Department of Biomedical Sciences Ontario Veterinary College · University of Guelph Guelph, Ontario The corticosteroids have been used extensively in Anti- Gluco- Sodium veterinary practice for the last 15 to 20 years. They inflammatory corticoid Retaining have offered the practitioners of veterinary medicine Compound Potency Potency Potency a tool useful for blocking a portion of the pathological 1-Jydrocortisone 1.01 1.02 1.01 changes seen in infectious and metabolic disease. Un­ Prednisolone 4.01 5.52 0.81 Cortisone 0.81 0.82 0.81 fortunately they have done little to advance the cause Triamcinolone 5.01 ~25.03 0.01 of specific disease therapy. I shall discuss the use of Betamethasone 102 - 25.01 ~25.03 0.01 corticosteroids by veterinarians in some conditions in Dexamethasone 102 - 25.01 ~25.03 0.01 Flumethasone ~75 -1004 ~75 - 1004 0.0 which they are widely employed and attempt to Predef (Fluoro- clarify their usefulness in some cases and their abuse prednisolone) 14.02 50.02 in others. Figure 2. Relative Potencies of Corticosteroids. First let us consider what the pharmacological properties of these agents are and which ones are most likely to be of therapeutic value (Figure 1). The titioner should select one that does not cause sodium ability of these agents to reduce an elevated retention in order to avoid the problems of edema for­ mation and fluid build-up that can be harmful to the 0 temperature, to reduce inflammatory and allergic "'O animal.
    [Show full text]
  • Effects of Ketone Bodies on Brain Metabolism and Function In
    International Journal of Molecular Sciences Review Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases Nicole Jacqueline Jensen 1,* , Helena Zander Wodschow 1, Malin Nilsson 1 and Jørgen Rungby 1,2 1 Department of Endocrinology, Bispebjerg University Hospital, 2400 Copenhagen, Denmark; [email protected] (H.Z.W.); malin.sofi[email protected] (M.N.); [email protected] (J.R.) 2 Copenhagen Center for Translational Research, Copenhagen University Hospital, Bispebjerg and Frederiksberg, 2400 Copenhagen, Denmark * Correspondence: [email protected] Received: 4 November 2020; Accepted: 18 November 2020; Published: 20 November 2020 Abstract: Under normal physiological conditions the brain primarily utilizes glucose for ATP generation. However, in situations where glucose is sparse, e.g., during prolonged fasting, ketone bodies become an important energy source for the brain. The brain’s utilization of ketones seems to depend mainly on the concentration in the blood, thus many dietary approaches such as ketogenic diets, ingestion of ketogenic medium-chain fatty acids or exogenous ketones, facilitate significant changes in the brain’s metabolism. Therefore, these approaches may ameliorate the energy crisis in neurodegenerative diseases, which are characterized by a deterioration of the brain’s glucose metabolism, providing a therapeutic advantage in these diseases. Most clinical studies examining the neuroprotective role of ketone bodies have been conducted in patients with Alzheimer’s disease, where brain imaging studies support the notion of enhancing brain energy metabolism with ketones. Likewise, a few studies show modest functional improvements in patients with Parkinson’s disease and cognitive benefits in patients with—or at risk of—Alzheimer’s disease after ketogenic interventions.
    [Show full text]
  • Gluconeogenesis and Bovine Ketosis
    October, 1968] NUTRITION REVIEWS 313 cattle at the time of slaughter showed no other two stations, but the differences effect of rearing practice on protein, iron, were insignificant. For some reason, the thiamine, riboflavin, or nicotinic acid vitamin A supplement added to the content. The fat content of this muscle concentrate was not very stable. As a increased with the higher level of con- result, vitamin A was low in the livers, centrates and restricted rearing area. With especially at two of the stations. However, Downloaded from https://academic.oup.com/nutritionreviews/article/26/10/313/1832143 by guest on 27 September 2021 this went a reduction in the moisture the method of rearing had no effect on content. The most outstanding observation this level. This was also true of the pro- was that the thiamine content of this mus- tein, iron, thiamine, riboflavin, niacin, cle of the animals at one station, at which pyridoxine, vitamin BIZ. and folic acid the most intensive feeding method was concentrations in the liver. studied, was almost twice that of the ani- Results of these studies indicate that mals at the other two stations. This was the method of rearing sheep and beef also true for the superficial digital flexer cattle has no significant effect on the muscle. There were, however, no such nutrient content of the same muscles or differences for any of the other nutrients studied. of the livers. There are inherent differences Livers from the animals at the station in the amounts of certain vitamins in dif- where the muscles had a high concentra- ferent muscles within the same animal tion of thiamine had slightly more thiamine and for the same muscle from different than livers of animals from either of the breeds.
    [Show full text]
  • 6 the Glycogen Storage Diseases and Related Disorders
    6 The Glycogen Storage Diseases and Related Disorders G. Peter A. Smit, Jan Peter Rake, Hasan O. Akman, Salvatore DiMauro 6.1 The Liver Glycogenoses – 103 6.1.1 Glycogen Storage Disease Type I (Glucose-6-Phosphatase or Translocase Deficiency) – 103 6.1.2 Glycogen Storage Disease Type III (Debranching Enzyme Deficiency) – 108 6.1.3 Glycogen Storage Disease Type IV (Branching Enzyme Deficiency) – 109 6.1.4 Glycogen Storage Disease Type VI (Glycogen Phosphorylase Deficiency) – 111 6.1.5 Glycogen Storage Disease Type IX (Phosphorylase Kinase Deficiency) – 111 6.1.6 Glycogen Storage Disease Type 0 (Glycogen Synthase Deficiency) – 112 6.2 The Muscle Glycogenoses – 112 6.2.1 Glycogen Storage Disease Type V (Myophosphorylase Deficiency) – 113 6.2.2 Glycogen Storage Disease Type VII (Phosphofructokinase Deficiency) – 113 6.2.3 Phosphoglycerate Kinase Deficiency – 114 6.2.4 Glycogen Storage Disease Type X (Phosphoglycerate Mutase Deficiency) – 114 6.2.5 Glycogen Storage Disease Type XII (Aldolase A Deficiency) – 114 6.2.6 Glycogen Storage Disease Type XIII (E-Enolase Deficiency) – 115 6.2.7 Glycogen Storage Disease Type XI (Lactate Dehydrogenase Deficiency) – 115 6.2.8 Muscle Glycogen Storage Disease Type 0 (Glycogen Synthase Deficiency) – 115 6.3 The Generalized Glycogenoses and Related Disorders – 115 6.3.1 Glycogen Storage Disease Type II (Acid Maltase Deficiency) – 115 6.3.2 Danon Disease – 116 6.3.3 Lafora Disease – 116 References – 116 102 Chapter 6 · The Glycogen Storage Diseases and Related Disorders Glycogen Metabolism Glycogen is a macromolecule composed of glucose viding glucose and glycolytic intermediates (. Fig. 6.1). units.
    [Show full text]
  • Glycogen Storage Diseases Are Genetic Deficiencies That Result in the Storage of Abnormal Amounts of Glycogen in the Body
    UNDERSTANDING GLYCOGEN STORAGE DISEASE What is Glycogen Storage Disease? Glycogen storage diseases are genetic deficiencies that result in the storage of abnormal amounts of glycogen in the body. About 1 out of 100 000 babies are born with glycogen storage diseases each year in Canada. There are 5 different types of these diseases depending on the enzyme missing, however, only type 1a will be described here. All people who are born with GSD have one thing in common. They are unable to properly metabolize or break down glycogen, the storage form of sugar in the body. The food we eat is usually used for growth, tissue repair and energy. The body stores what it does not use. Excess sugar, or glucose, is stored as glycogen in the liver and muscle tissue. Between meals and during sleep (i.e. periods of fasting), or during exercise, the body breaks down glycogen and uses the stored sugar for energy. Due to an enzyme deficiency, people with GSD have the ability to store sugar as glycogen but are unable to use these stores to provide the body with energy during fasting or exercise. Think of a pantry where extra food is stored. In times of need, the pantry door can be opened and food can be accessed. In glycogen storage disease, food can be placed in the pantry for storage, but can’t be accessed in times of need. The pantry door is locked. Food can be pushed through a slot in the door but the door cannot be opened to get the food out.
    [Show full text]
  • Advances in Biochemistry & Applications in Medicine
    Advances in Biochemistry & Applications in Medicine Chapter 3 Inborn Errors of Metabolism Arvind Kumar Shakya School of Sciences, Indira Gandhi National Open University, New Delhi-110068 (India) Tel: 8447106178; Email: [email protected] 1. Introduction Inborn errors of metabolism (IEM) are a group of inherited metabolic disorders leading to enzymatic defects in the human metabolism. As its name implies, inborn errors means birth defects in newborn infants which passed down from family and affecting metabolism. Hence, it is called Inborn errors of metabolism or inherited metabolic disorders. IEM can appear at birth or later in life such as phenylketonuria, albinism, lactose intolerance, gaucher disease, fabry disease etc. IEM refers a condition where in body’s metabolism is affected due to genetic disorders. The cause of IEM is mutations in a gene that code for an enzyme leading to synthe- sis of defective enzyme activity or deficiency of an enzyme that affects the normal function of a metabolic pathway. The main indication of IEM is an excess storage or accumulation of specific metabolites in tissues, organs and blood which further manifest to health diseases. In last decades, several hundreds of different IEM have been identified. Most IEM are rare but some are life threatening. Although, most people do not know what inherited metabolic disor- ders are and may never have heard of them. Therefore, in this chapter, you are going to study the basic concept, genetic basis and metabolic consequences of inborn errors of metabolism. You will learn about metabolic defec- tive enzymes, clinical symptoms, diagnosis, and treatment of metabolic disorders of amino acids, carbohydrates, lipids, purines and pyrimidines.
    [Show full text]
  • Metabolic Switching Is Impaired by Aging and Facilitated by Ketosis
    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.12.874297; this version posted December 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 1 Metabolic switching is impaired by aging and facilitated by 2 ketosis independent of glycogen 3 Abbi R. Hernandez1, Leah M. Truckenbrod1, Quinten P. Federico1, Keila T. Campos1, Brianna 4 M. Moon1, Nedi Ferekides1, Meagan Hoppe1, Dominic D’Agostino3, 4, Sara N. Burke1, 2* 5 1Department of Neuroscience, University of Florida, Gainesville, FL, USA; 2Intitute on Aging, 6 University of Florida, Gainesville, FL, USA; 3Department of Molecular Pharmacology and 7 Physiology, University of South Florida, Tampa, FL, USA; 4Institute for Human and Machine 8 Cognition, Ocala, FL, USA 9 *Corresponding Author 10 [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.12.874297; this version posted December 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 11 ABSTRACT 12 The ability to switch between glycolysis and ketosis promotes survival by enabling 13 metabolism through fat oxidation during periods of fasting. Carbohydrate restriction or stress can 14 also elicit metabolic switching. Keto-adapting from glycolysis is delayed in aged rats, but factors 15 mediating this age-related impairment have not been identified.
    [Show full text]